Hospital Acquired Infections Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Test (Molecular, Conventional), By Infection (UTI, Pneumonia), By Product, By Type, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Test
                       1.1.2. Infection
                       1.1.3. Product
                       1.1.4. Type
                       1.1.5. Regional scope
                       1.1.6. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Test outlook
                       2.2.2. Infection outlook
                       2.2.3. Product outlook
                       2.2.4. Type outlook
                       2.2.5. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Hospitals Acquired Infections Diagnostics Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Market Dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                   3.4. Hospitals Acquired Infections Diagnostics Market Analysis Tools
                       3.4.1. Industry Analysis - Porter’s
                           3.4.1.1. Supplier power
                           3.4.1.2. Buyer power
                           3.4.1.3. Substitution threat
                           3.4.1.4. Threat of new entrant
                           3.4.1.5. Competitive rivalry
                       3.4.2. PESTEL Analysis
                           3.4.2.1. Political landscape
                           3.4.2.2. Technological landscape
                           3.4.2.3. Economic landscape
Chapter 4. Hospitals Acquired Infections Diagnostics: Test Estimates & Trend Analysis
                   4.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
                   4.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   4.3. Conventional
                       4.3.1. Conventional market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.4. Molecular
                       4.4.1. Molecular market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Hospital Acquired Infections Diagnostics: Infection Estimates & Trend Analysis
                   5.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
                   5.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   5.3. UTI
                       5.3.1. UTI market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.4. Pneumonia
                       5.4.1. Pneumonia market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.5. Surgical Site Infection
                       5.5.1. Surgical site infection market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.6. Blood Stream Infections
                       5.6.1. Blood stream infections market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.7. Others
                       5.7.1. Others infections market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Hospital Acquired Infections Diagnostics: Product Estimates & Trend Analysis
                   6.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
                   6.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   6.3. Consumables
                       6.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.4. Instruments
                       6.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Hospital Acquired Infections Diagnostics Market: Type Estimates & Trend Analysis
                   7.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
                   7.2. Type Outlook
                       7.2.1. Type Outlook market estimates and forecasts, 2018 to 2030 (USD Million)
                   7.3. Blood Tests
                       7.3.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
                   7.4. Urinalysis
                       7.4.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Hospital Acquired Infections Diagnostics Market: Regional Estimates & Trend Analysis
                   8.1. Regional Outlook
                   8.2. Hospitals Acquired Infections Diagnostics Market by Region: Key Takeaways
                   8.3. North America
                       8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.3.2. U.S.
                           8.3.2.1. Key Country Dynamics
                           8.3.2.2. Competitive Scenario
                           8.3.2.3. Regulatory Framework
                           8.3.2.4. Reimbursement Scenario
                           8.3.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.3.3. Canada
                           8.3.3.1. Key Country Dynamics
                           8.3.3.2. Competitive Scenario
                           8.3.3.3. Regulatory Framework
                           8.3.3.4. Reimbursement Scenario
                           8.3.3.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.3.4. Mexico
                           8.3.4.1. Key Country Dynamics
                           8.3.4.2. Competitive Scenario
                           8.3.4.3. Regulatory Framework
                           8.3.4.4. Reimbursement Scenario
                           8.3.4.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   8.4. Europe
                       8.4.1. UK
                           8.4.1.1. Key Country Dynamics
                           8.4.1.2. Competitive Scenario
                           8.4.1.3. Regulatory Framework
                           8.4.1.4. Reimbursement Scenario
                           8.4.1.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.4.2. Germany
                           8.4.2.1. Key Country Dynamics
                           8.4.2.2. Competitive Scenario
                           8.4.2.3. Regulatory Framework
                           8.4.2.4. Reimbursement Scenario
                           8.4.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.4.3. France
                           8.4.3.1. Key Country Dynamics
                           8.4.3.2. Competitive Scenario
                           8.4.3.3. Regulatory Framework
                           8.4.3.4. Reimbursement Scenario
                           8.4.3.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.4.4. Italy
                           8.4.4.1. Key Country Dynamics
                           8.4.4.2. Competitive Scenario
                           8.4.4.3. Regulatory Framework
                           8.4.4.4. Reimbursement Scenario
                           8.4.4.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.4.5. Spain
                           8.4.5.1. Key Country Dynamics
                           8.4.5.2. Competitive Scenario
                           8.4.5.3. Regulatory Framework
                           8.4.5.4. Reimbursement Scenario
                           8.4.5.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.4.6. Denmark
                           8.4.6.1. Key Country Dynamics
                           8.4.6.2. Competitive Scenario
                           8.4.6.3. Regulatory Framework
                           8.4.6.4. Reimbursement Scenario
                           8.4.6.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.4.7. Sweden
                           8.4.7.1. Key Country Dynamics
                           8.4.7.2. Competitive Scenario
                           8.4.7.3. Regulatory Framework
                           8.4.7.4. Reimbursement Scenario
                           8.4.7.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.4.8. Norway
                           8.4.8.1. Key Country Dynamics
                           8.4.8.2. Competitive Scenario
                           8.4.8.3. Regulatory Framework
                           8.4.8.4. Reimbursement Scenario
                           8.4.8.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   8.5. Asia Pacific
                       8.5.1. Japan
                           8.5.1.1. Key Country Dynamics
                           8.5.1.2. Competitive Scenario
                           8.5.1.3. Regulatory Framework
                           8.5.1.4. Reimbursement Scenario
                           8.5.1.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.5.2. China
                           8.5.2.1. Key Country Dynamics
                           8.5.2.2. Competitive Scenario
                           8.5.2.3. Regulatory Framework
                           8.5.2.4. Reimbursement Scenario
                           8.5.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.5.3. India
                           8.5.3.1. Key Country Dynamics
                           8.5.3.2. Competitive Scenario
                           8.5.3.3. Regulatory Framework
                           8.5.3.4. Reimbursement Scenario
                           8.5.3.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.5.4. Australia
                           8.5.4.1. Key Country Dynamics
                           8.5.4.2. Competitive Scenario
                           8.5.4.3. Regulatory Framework
                           8.5.4.4. Reimbursement Scenario
                           8.5.4.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.5.5. Thailand
                           8.5.5.1. Key Country Dynamics
                           8.5.5.2. Competitive Scenario
                           8.5.5.3. Regulatory Framework
                           8.5.5.4. Reimbursement Scenario
                           8.5.5.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.5.6. South Korea
                           8.5.6.1. Key Country Dynamics
                           8.5.6.2. Competitive Scenario
                           8.5.6.3. Regulatory Framework
                           8.5.6.4. Reimbursement Scenario
                           8.5.6.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   8.6. Latin America
                       8.6.1. Brazil
                           8.6.1.1. Key Country Dynamics
                           8.6.1.2. Competitive Scenario
                           8.6.1.3. Regulatory Framework
                           8.6.1.4. Reimbursement Scenario
                           8.6.1.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.6.2. Argentina
                           8.6.2.1. Key Country Dynamics
                           8.6.2.2. Competitive Scenario
                           8.6.2.3. Regulatory Framework
                           8.6.2.4. Reimbursement Scenario
                           8.6.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   8.7. MEA
                       8.7.1. South Africa
                           8.7.1.1. Key Country Dynamics
                           8.7.1.2. Competitive Scenario
                           8.7.1.3. Regulatory Framework
                           8.7.1.4. Reimbursement Scenario
                           8.7.1.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.7.2. Saudi Arabia
                           8.7.2.1. Key Country Dynamics
                           8.7.2.2. Competitive Scenario
                           8.7.2.3. Regulatory Framework
                           8.7.2.4. Reimbursement Scenario
                           8.7.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.7.3. UAE
                           8.7.3.1. Key Country Dynamics
                           8.7.3.2. Competitive Scenario
                           8.7.3.3. Regulatory Framework
                           8.7.3.4. Reimbursement Scenario
                           8.7.3.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       8.7.4. Kuwait
                           8.7.4.1. Key Country Dynamics
                           8.7.4.2. Competitive Scenario
                           8.7.4.3. Regulatory Framework
                           8.7.4.4. Reimbursement Scenario
                           8.7.4.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
                   9.1. Recent Developments & Impact Analysis, By Key Market Participants
                   9.2. Company/Competition Categorization
                   9.3. Company Market Share Analysis, 2024
                   9.4. Company Profiles
                       9.4.1. BIOMÉRIEUX
                           9.4.1.1. Company overview
                           9.4.1.2. Financial performance
                           9.4.1.3. Product benchmarking
                           9.4.1.4. Strategic initiatives
                       9.4.2. Abbott
                           9.4.2.1. Company overview
                           9.4.2.2. Financial performance
                           9.4.2.3. Product benchmarking
                           9.4.2.4. Strategic initiatives
                       9.4.3. F. Hoffmann-La Roche Ltd
                           9.4.3.1. Company overview
                           9.4.3.2. Financial performance
                           9.4.3.3. Product benchmarking
                           9.4.3.4. Strategic initiatives
                       9.4.4. Siemens Healthcare Private Limited
                           9.4.4.1. Company overview
                           9.4.4.2. Financial performance
                           9.4.4.3. Product benchmarking
                           9.4.4.4. Strategic initiatives
                       9.4.5. BD (Becton, Dickinson and Company)
                           9.4.5.1. Company overview
                           9.4.5.2. Financial performance
                           9.4.5.3. Product benchmarking
                           9.4.5.4. Strategic initiatives
                       9.4.6. Hologic, Inc.
                           9.4.6.1. Company overview
                           9.4.6.2. Financial performance
                           9.4.6.3. Product benchmarking
                           9.4.6.4. Strategic initiatives
                       9.4.7. Meridian Bioscience, Inc
                           9.4.7.1. Company overview
                           9.4.7.2. Financial performance
                           9.4.7.3. Product benchmarking
                           9.4.7.4. Strategic initiatives
                       9.4.8. QIAGEN
                           9.4.8.1. Company overview
                           9.4.8.2. Financial performance
                           9.4.8.3. Product benchmarking
                           9.4.8.4. Strategic initiatives
                       9.4.9. Thermo Fisher Scientific Inc.
                           9.4.9.1. Company overview
                           9.4.9.2. Financial performance
                           9.4.9.3. Product benchmarking
                           9.4.9.4. Strategic initiatives
                       9.4.10. Bioscience, Inc.
                           9.4.10.1. Company overview
                           9.4.10.2. Financial performance
                           9.4.10.3. Product benchmarking
                           9.4.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 3 North America hospital acquired infections diagnostics market, by infection Type, 2018 - 2030 (USD Million)
Table 4 North America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 5 North America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 6 North America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 8 U.S. hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 9 U.S. hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 11 Canada hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 12 Canada hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 13 Canada hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 14 Canada hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 15 Mexico hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 16 Mexico hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 17 Mexico hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 18 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 19 Europe hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 20 Europe hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 21 Europe hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 22 Europe hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 23 UK hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 24 UK hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 25 UK hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 26 UK hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 27 Germany hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 28 Germany hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 29 Germany hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 30 Germany hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 31 France hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 32 France hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 33 France hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 France hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 35 Italy hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 36 Italy hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 37 Italy hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 Italy hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 39 Spain hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 40 Spain hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 41 Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 43 Denmark hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 44 Denmark hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 45 Denmark hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 46 Denmark hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 47 Sweden hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 48 Sweden hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 49 Sweden hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 50 Sweden hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 51 Norway hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 52 Norway hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 53 Norway hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 Norway hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 55 Asia Pacific hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 56 Asia Pacific hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 57 Asia Pacific hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 Asia Pacific hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 59 Asia Pacific hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 60 Japan hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 61 Japan hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 62 Japan hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 63 Japan hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 64 China hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 65 China hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 66 China hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 67 China hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 68 India hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 69 India hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 70 India hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 71 India hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 72 Australia hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 73 Australia hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 74 Australia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 75 Australia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 76 Thailand hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 77 Thailand hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 78 Thailand hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 79 Thailand hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 80 South Korea hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 81 South Korea hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 82 South Korea hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 83 South Korea hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 84 Latin America hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 85 Latin America hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 86 Latin America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 87 Latin America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 88 Latin America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 89 Brazil hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 90 Brazil hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 91 Brazil hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 92 Brazil hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 93 Argentina hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 94 Argentina hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 95 Argentina hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 96 Argentina hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 97 Middle East and Africa hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 102 South Africa hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 103 South Africa hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 104 South Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 105 South Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 110 UAE hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 111 UAE hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 112 UAE hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 113 UAE hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 114 Kuwait hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
Table 115 Kuwait hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
Table 116 Kuwait hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 117 Kuwait hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Microneedle Instruments systems: market outlook
Fig. 8 Hospital Acquired Infections Diagnostics competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Hospital acquired infections diagnostics market driver impact
Fig. 13 Hospital acquired infections diagnostics market restraint impact
Fig. 14 Hospital acquired infections diagnostics market strategic initiatives analysis
Fig. 15 Hospital acquired infections diagnostics market: Test type movement analysis
Fig. 16 Hospital acquired infections diagnostics market: Test type outlook and key takeaways
Fig. 17 Molecular market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Conventional market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Hospital acquired infections diagnostics market: Infection type movement analysis
Fig. 20 Hospital acquired infections diagnostics market: Infection type outlook and key takeaways
Fig. 21 UTI market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Pneumonia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Surgical site infection market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Blood stream infections market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Hospital acquired infections diagnostics market: Product movement analysis
Fig. 27 Hospital acquired infections diagnostics market: Product outlook and key takeaways
Fig. 28 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 2030 Hospital Acquired Infections Diagnostics market: Type outlook and key takeaways
Fig. 31 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Urinalysis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Global hospital acquired infections diagnostics market: Regional movement analysis
Fig. 35 Global hospital acquired infections diagnostics market: Regional outlook and key takeaways
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)